Table 2:
Medulloblastoma Subgroups | Percentage Correct in Discovery Cohort | Percentage Correct in Validation Cohort |
---|---|---|
Total | 66% | 65% |
WNT | 75% | 50% |
SHH | 54% | 73% |
Group 3 | 92% | 83% |
Group 4 | 59% | 58% |
Medulloblastoma Subgroups | Percentage Correct in Discovery Cohort | Percentage Correct in Validation Cohort |
---|---|---|
Total | 66% | 65% |
WNT | 75% | 50% |
SHH | 54% | 73% |
Group 3 | 92% | 83% |
Group 4 | 59% | 58% |